Graphic: Vioxx Legal Resources.com
Offices

Image: Gavel & Law Books
Attorney Advertising Disclaimer

 


Vioxx News Article
September 15, 2005
San Francisco Chronicle, "Vioxx Judge Reprimands Merck Lawyer"
          The judge hearing a product liability suit against Merck & Co., the manufacturer of painkiller Vioxx, reprimanded the drug maker's lead lawyer Thursday for violating pretrial instructions barring comments about lawyers in front of the jury.
          Threatening to declare a mistrial, Superior Court Judge Carol E. Higbee said Merck lawyer Diane Sullivan had made repeated negative references about attorneys in her opening statement to jurors Wednesday, despite being told beforehand not to do so.
          "It's simply playing to the bias of jurors ... a certain perception that there are too many lawsuits and that it's causing society problems," Higbee said.
          In Wednesday's opening, Sullivan made reference to plaintiff Frederick "Mike" Humeston being "surrounded by lawyers" and later criticized Humeston's attorneys' interpretation of evidence by saying, "That's not science, that's lawyering, lawyering, lawyering."
          The start of testimony Thursday was delayed by Higbee's criticism and a dispute over whether Whitehouse Station, N.J.-based Merck would be allowed to admit into evidence a key 2005 memo from a Food and Drug Administration advisory committee.
          Humeston, a 60-year-old postal worker from Boise, Idaho, alleges Vioxx caused him to suffer a heart attack four years ago. His lawyers told jurors on Wednesday, the first day of testimony, that Merck rushed the product onto the market, ignored evidence of problems with some patients and didn't warn doctors or users that Vioxx could increase the risk of heart attacks and strokes.
          Merck withdrew the popular arthritis and pain treatment from the market in September 2004 after its own research showed Vioxx doubled risk of heart attack and stroke after 18 months' use.

Lieff Cabraser: Experienced Vioxx Injury Lawyers
Founded in 1972, Lieff Cabraser Heimann & Bernstein, LLP is an over-fifty attorney law firm with offices in San Francisco, New York and Nashville. In each of the last five years, the National Law Journal has recognized Lieff Cabraser as one of the top plaintiffs’ law firms in America.
For our personal injury Vioxx cases, we bring a team of experienced lawyers. In addition, we have on staff multiple nurses, legal assistants, scientific analysts and case clerks to assist our Vioxx attorneys. Learn more about advantages we offer patients with Vioxx problems and injuries.
OUR PROMISE TO YOU
We have a nationwide team of experienced injury Vioxx lawyers assigned to Vioxx trials.
We provide individual attentive service. Learn more about our firm.
We have retained the leading national medical experts on Vioxx and have a staff of nurses to assist the prosecution of the claims of our clients.
We have been contacted by thousands of Vioxx drug patients nationwide as part of the Vioxx litigation. We have represented patients who ingested prescription drugs with dangerous, undisclosed side effects in personal injury lawsuits across America, including residents of Alaska, Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia and Wyoming.
Persons living outside the United States who have been injured by an American product manufactured may also in certain cases file Vioxx lawsuits for compensation for heart attacks and strokes in United States courts.

Photo: Supreme Court, Gavel & Law Books, Scales, various pill images
Lieff Cabraser Heimann & Bernstein, LLP

Trademark Notice
"Vioxx" is a registered trademark of Merck. Lieff Cabraser Heimann & Bernstein, LLP is in no way affiliated with Merck, and the Vioxx trademark is used solely for informational purposes.

Copyright © 2008 Lieff Cabraser Heimann & Bernstein, LLP

Vioxx Recall: The international prescription drug company Merck announced in September 2004 the worldwide withdrawal of the arthritis medication Rofecoxib, sold in most countries under the brand name Vioxx, because a study showed an increased risk of heart attack and stroke.

Vioxx Trial: Patients who have suffered injuries due to Vioxx have filed litigation against Merck for selling Vioxx even though Merck allegedly was aware of Vioxx's dangerous side effects.